Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This study will assess the safety and efficacy of ixekizumab (LY2439821) compared to placebo in participants with active AS.
Epistemonikos ID: cef5a0a34952b36d2c9434b483e814fbe45d4476
First added on: May 11, 2024